Retatrutide
Retatrutide is a synthetic triple agonist that binds GLP-1, GIP and glucagon receptors. It is studied in preclinical and clinical research in relation to metabolism and weight regulation.
What is Retatrutide?
Retatrutide is a synthetic triple agonist that binds GLP-1, GIP and glucagon receptors. It is studied in preclinical and clinical research in relation to metabolism and weight regulation. This page is intended solely as an informational research guide for laboratory applications (Research Use Only).
Mechanism (preclinical)
Combined agonist activity at incretin and glucagon receptors affects glucose homeostasis, energy expenditure and appetite in models.
Research areas
- Glucose and lipid metabolism
- Weight regulation (preclinical)
- Incretin research (GLP-1 / GIP)
- Energy expenditure
Specifications
- Molecular weight
- ≈ 4,731 Da
- Purity
- ≥ 99%
- Synonyms
- LY-3437943
- Form
- Lyophilised powder
- Included
- 3 ml bacteriostatic water
Storage and reconstitution
Dry (lyophilised) powder can be stored long-term at -20 to -80 °C in an airtight, opaque container. After reconstitution with bacteriostatic water the solution must be refrigerated at 2 to 8 °C and protected from light.
Order Retatrutide from Europa Peptides
Europa Peptides supplies Retatrutide as lyophilised powder with ≥ 99% purity - 3 ml bacteriostatic water included. Shipped from our Netherlands warehouse. Orders placed before 16:00 on a business day ship the same day. For laboratory research only (RUO).